Safety of the adjuvanted recombinant zoster vaccine in adults aged 50Â years or older. A phase IIIB, non-randomized, multinational, open-label study in previous ZOE-50 and ZOE-70 placebo recipients
Ocran-Appiah, Josephine, Boutry, Céline, Hervé, Caroline, Soni, Jyoti, Schuind, AnneJournal:
Vaccine
DOI:
10.1016/j.vaccine.2020.10.029
Date:
December, 2020
File:
PDF, 946 KB
2020